HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pagani, F. Articles by Baralle, F. E. Search for Related Content PubMed PubMed Citation Articles by Pagani, F. Articles by Baralle, F. E. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 31, 1371-1377, Copyright © 1990 by Lipid Research, Inc.

ARTICLES

Human apolipoprotein A-I gene promoter polymorphism: association with hyperalphalipoproteinemia

F Pagani, A Sidoli, GA Giudici, L Barenghi, C Vergani and FE Baralle
Laboratory of Biochemistry and Molecular Biology, Fondazione Rivetti, Milan, Italy.

An apolipoprotein A-I gene promoter polymorphism, due to an adenine (A) to guanine (G) transition 78 base pairs upstream from the transcription initiation site, was studied by amplification of the corresponding region of the apoA-I gene, DNA sequencing, and allele-specific oligonucleotide hybridization. The frequency of the polymorphism was studied on female and male individuals classified into three groups according to the high density lipoprotein (HDL) cholesterol concentration. The allelic frequencies for the A polymorphism were 0.10, 0.14, 0.27 in women and 0.08, 0.17, 0.14 in men in the lowest, in the intermediate (between 10th and 90th percentile), and the highest decile of HDL cholesterol levels, respectively. Statistical analysis showed a significant difference of allelic frequencies between the highest and the lowest deciles (P less than 0.006) and between the highest and the intermediate deciles of HDL cholesterol in women (P less than 0.04) but not in men. As the sequences surrounding the polymorphism are known to be involved in transcription modulation, it is possible that the A-G transition polymorphism may have an influence on apoA-I synthesis and, in consequence, on the HDL cholesterol levels in women.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M Ordovas Genetic interactions with diet influence the risk of cardiovascular disease Am. J. Clinical Nutrition, February 1, 2006; 83(2): 443S - 446S. [Abstract] [Full Text] [PDF]

				C. Marin, J. Lopez-Miranda, P. Gomez, E. Paz, P. Perez-Martinez, F. Fuentes, J. A. Jimenez-Pereperez, J. M. Ordovas, and F. Perez-Jimenez Effects of the human apolipoprotein A-I promoter G-A mutation on postprandial lipoprotein metabolism Am. J. Clinical Nutrition, August 1, 2002; 76(2): 319 - 325. [Abstract] [Full Text] [PDF]

				J. M Ordovas, D. Corella, L A. Cupples, S. Demissie, A. Kelleher, O. Coltell, P. W. Wilson, E. J Schaefer, and K. Tucker Polyunsaturated fatty acids modulate the effects of the APOA1 G-A polymorphism on HDL-cholesterol concentrations in a sex-specific manner: the Framingham Study Am. J. Clinical Nutrition, January 1, 2002; 75(1): 38 - 46. [Abstract] [Full Text] [PDF]

				M. Groenendijk, R. M. Cantor, T. W. A. De Bruin, and G. M. Dallinga-Thie New genetic variants in the apoA-I and apoC-III genes and familial combined hyperlipidemia J. Lipid Res., February 1, 2001; 42(2): 188 - 194. [Abstract] [Full Text]

				M. Groenendijk, R. M. Cantor, N. H. H. C. Blom, J. I. Rotter, T. W. A. de Bruin, and G. M. Dallinga-Thie Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia J. Lipid Res., June 1, 1999; 40(6): 1036 - 1044. [Abstract] [Full Text]

				A. Matsunaga, J. Sasaki, H. Han, W. Huang, M. Kugi, T. Koga, S. Ichiki, T. Shinkawa, and K. Arakawa Compound Heterozygosity for an Apolipoprotein A1 Gene Promoter Mutation and a Structural Nonsense Mutation With Apolipoprotein A1 Deficiency Arterioscler. Thromb. Vasc. Biol., February 1, 1999; 19(2): 348 - 355. [Abstract] [Full Text] [PDF]

				B. Vedie, X. Jeunemaitre, J. L. Megnien, I. Myara, H. Trebeden, A. Simon, and N. Moatti Charge Heterogeneity of LDL in Asymptomatic Hypercholesterolemic Men Is Related to Lipid Parameters and Variations in the ApoB and CIII Genes Arterioscler. Thromb. Vasc. Biol., November 1, 1998; 18(11): 1780 - 1789. [Abstract] [Full Text] [PDF]

				H. Gylling, K. Kontula, U.-M. Koivisto, H. E. Miettinen, and T. A. Miettinen Polymorphisms of the Genes Encoding Apoproteins A-I, B, C-III, and E and LDL Receptor, and Cholesterol and LDL Metabolism During Increased Cholesterol Intake: Common Alleles of the Apoprotein E Gene Show the Greatest Regulatory Impact Arterioscler. Thromb. Vasc. Biol., January 1, 1997; 17(1): 38 - 44. [Abstract] [Full Text]

				S. H. Hong, W. H. Park, C. C. Lee, J. H. Song, and J. Q Kim Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects Clin. Chem., January 1, 1997; 43(1): 13 - 17. [Abstract] [Full Text] [PDF]

				X. Zhang, Z.-Q. Chen, Z. Wang, W. Mohan, and S.-P. Tam Protein-DNA Interactions at a Drug-responsive Element of the Human Apolipoprotein A-I Gene J. Biol. Chem., October 25, 1996; 271(43): 27152 - 27160. [Abstract] [Full Text] [PDF]

				A. Minnich, G. DeLangavant, J. Lavigne, G. Roederer, S. Lussier-Cacan, and J. Davignon G->A Substitution at Position -75 of the Apolipoprotein A-I Gene Promoter : Evidence Against a Direct Effect on HDL Cholesterol Levels Arterioscler. Thromb. Vasc. Biol., October 1, 1995; 15(10): 1740 - 1745. [Abstract] [Full Text]

				M. Marcil, B. Boucher, L. Krimbou, B. C. Solymoss, J. Davignon, J. Frohlich, and J. Genest Jr Severe Familial HDL Deficiency in French-Canadian Kindreds : Clinical, Biochemical, and Molecular Characterization Arterioscler. Thromb. Vasc. Biol., August 1, 1995; 15(8): 1015 - 1024. [Abstract] [Full Text]